Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07140120 · ClinicalTrials.gov registry record

LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study

A clinical trial of Cirrhosis, Liver and Portal Hypertension, sponsored by University of Michigan.

Active
Registry status
52
Enrollment target
3
Study locations

NCT07140120 is a study of Cirrhosis, Liver and Portal Hypertension that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 52 participants, below the 241-participant average among 34 other Cirrhosis, Liver trials with a reported enrollment target (78% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07140120, a study of Cirrhosis, Liver and Portal Hypertension, is active but no longer recruiting, sponsored by University of Michigan.

ACTIVE NOT RECRUITING
Registry status
52 participants
Enrollment target
3
Study locations

Study Summary

The LIVE-SMART supplementary study will assess social determinants of health (income, education, neighborhood deprivation), financial burden (out-of-pocket costs, productivity loss), financial distress (patient and caregiver-reported outcomes), and financial toxicity (healthcare utilization) among LIVE-SMART participants and their caregivers. Participants for this supplementary study are participants in the primary study (NCT05794555) and their caregivers.

Study Locations (3)

Michigan

  • University of Michigan - Ann Arbor

Pennsylvania

  • University of Pennsylvania - Philadelphia

Texas

  • Baylor Scott & White Research Institute (BSW) - Dallas

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2023-06-13
Est. Completion 2026-06

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT07140120

The ClinicalTrials.gov registry entry for NCT07140120 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 241-participant average among 34 other Cirrhosis, Liver trials with a reported enrollment target (78% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cirrhosis, Liver appearing as the primary indexed condition, and to 0 interventions.

NCT07140120 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Michigan, Pennsylvania, Texas.

Frequently Asked Questions

What is clinical trial NCT07140120 about?

NCT07140120 is a clinical study titled "LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study". The LIVE-SMART supplementary study will assess social determinants of health (income, education, neighborhood deprivation), financial burden (out-of-pocket costs, productivity loss), financial distress (patient and caregiver-reported outcomes), and financial toxicity (healthcare utilization) among L...

What is the current status of trial NCT07140120?

This trial is currently active not recruiting. The enrollment target is 52 participants. The study started on 2023-06-13. Estimated completion is 2026-06.

What conditions does trial NCT07140120 study?

This clinical trial studies the following conditions: Cirrhosis, Liver, Portal Hypertension.

Who is sponsoring clinical trial NCT07140120?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07140120 being conducted?

This trial has 3 study locations across Michigan, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cirrhosis, Liver

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.